Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye Trials

    Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye Trials

    FromOIS Podcast | Ophthalmology's leading Podcast

    Start listeningView podcast show

    Eleven’s Celniker Talks Leadership, Public Markets, and Phase III Dry Eye Trials

    FromOIS Podcast | Ophthalmology's leading Podcast

    ratings:
    Length:
    18 minutes
    Released:
    Jan 6, 2015
    Format:
    Podcast episode

    Description

    Eleven Biotherapeutics capitalized on exciting technology and promising clinical results for its lead Dry Eye product to stage a successful IPO in 2014. Abbie C. Celniker, PhD, President and CEO, talks frankly about her leadership style, dealing with public investors, and how she’s man-aging high expectations for lead product EBI-005.
    Released:
    Jan 6, 2015
    Format:
    Podcast episode

    Titles in the series (100)

    Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.